Correlation Between Allarity Therapeutics and Lixte Biotechnology

Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allarity Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Allarity Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Lixte Biotechnology.

Diversification Opportunities for Allarity Therapeutics and Lixte Biotechnology

0.49

Correlation Coefficient

Allarity Therapeutics  Lixte Biotechnology

Very weak diversification

The 3 months correlation between Allarity and Lixte is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Lixte Biotechnology go up and down completely randomly.

Pair Corralation between Allarity Therapeutics and Lixte Biotechnology

Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 1.21 times more return on investment than Lixte Biotechnology. However, Allarity Therapeutics is 1.21 times more volatile than Lixte Biotechnology Holdings. It trades about 0.02 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about -0.08 per unit of risk. If you would invest  112.00  in Allarity Therapeutics on December 29, 2024 and sell it today you would lose (8.00) from holding Allarity Therapeutics or give up 7.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Allarity Therapeutics  vs.  Lixte Biotechnology Holdings

Allarity Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Allarity Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating essential indicators, Allarity Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Lixte Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lixte Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Allarity Therapeutics and Lixte Biotechnology

The main advantage of trading using opposite Allarity Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.

The idea behind Allarity Therapeutics and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.